Harnessing AI for Drug Discovery Certara Amplifies CODEX Platform Capabilities
Certara, a leader in biosimulation, has recently expanded the horizons of AI in drug discovery with the introduction of artificial …
Biopharma Insights
Collaboration Between Iktos and Curreio Harnesses AI and Cryo-EM for Drug Discovery
Iktos, a French AI-focused company specializing in new drug design, and Curreio, a Japanese cryo-electron microscopy (cryo-EM) expert, have recently …
CEPI and aVaxziPen Partner to Advance Needle-Free Vaccine Delivery Aiming for Equitable Global Access
Needle-free vaccine delivery has emerged as a promising solution to overcome the challenges associated with frozen storage requirements, thereby improving …
BenevolentAI Pioneers AI-Driven Drug Discovery for ALS Treatment
Incorporating AI in drug discovery is rapidly becoming a common practice in the pharmaceutical industry. The recent undertakings of UK-based …
Owkin Advances AI in Drug Discovery with Launching $50 Million MOSAIC Project
Owkin, an AI biotech firm, is partnering with NanoString Technologies and other notable cancer research institutions to spearhead the MOSAIC …
ReproCell, IBM, and HNCDI Debut Pharmacology-AI to Boost Efficiency of Drug Discovery
ReproCell, a well-established life sciences company, recently revealed its latest service offering, Pharmacology-AI. This service is the result of a …
Seqera Labs Joins Forces with Genomics England to Boost Genomic Medicine Research
Seqera Labs, recognized for its secure workflow orchestration software in the life sciences domain, is aligning forces with Genomics England, …
FDA IND Approval of AI-derived Cancer Drug ISM3091 Marks a Milestone for Insilico Medicine
In an essential leap forward for the utilization of artificial intelligence (AI) in drug discovery, Insilico Medicine secured Investigational New …
Eli Lilly Collaborates with XtalPi to Harness AI in Drug Discovery
XtalPi Inc., a company that uses artificial intelligence (AI) and automation in pharmaceutical technology, is set to collaborate with Eli …
Neuralink's Journey and the Broadening Horizons of Brain-Computer Interface Technology
Neuralink, Elon Musk's brain-implant company, has just revealed that it received approval from the U.S. Food and Drug Administration (FDA) …
Valo Therapeutics' Innovative Immuno-Oncology Therapy PeptiCRAd-1 Begins Human Trials
Valo Therapeutics Oy (ValoTx), a frontrunner in the development of advanced immunotherapies for cancer, has initiated its Phase I trial …
How Syntekabio’s Supercomputing Enables AI-driven Drug Discovery
What is "supercomputing"? It refers to processing a massive quantity of complex data-intensive and computation-heavy problems often found in scientific …